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Abstract
Background The ABCD
2 score is increasingly being used
to triage patients with transient ischemic attack (TIA).
Whether the score can predict the need for in-hospital
intervention (IHI), other than initiation of antiplatelets and
statins, is unknown.
Aims The ability of the ABCD
2 score to predict IHI would
strengthen the rationale to use it as a decision-making tool.
We thus conducted this study to investigate the relationship
between the ABCD
2 score and IHI.
Methods We analyzed prospectively collected data from
consecutive TIA patients over 12 months. We determined
ABCD
2 upon admission and collected the results of in-hospital
evaluation, treatments initiated during hospitalization, and
follow-up status. We defined IHI as arterial revascularization
or anticoagulation required during admission. We used chi-
square for trend to examine the association between ABCD
2
and IHI.
Results We studied 121 patients. Fourteen (12%) had small
infarcts on diffusion magnetic resonance imaging; 38 (31%)
had a new risk factor recognized during admission
[hyperlipidemia (n=9), hypertension (1), diabetes (1),
carotid stenosis ≥ 50% (16), other arterial occlusive lesions
(7), and potential cardioembolic source (4)]. Their percen-
tages increased with higher ABCD
2 scores. However,
among 12 patients (10%) with IHI, ABCD
2 score categories
were equally distributed (10% in 0–3, 9% in 4–5, and 10%
in 6–7; p=0.8). One patient (0.8%) worsened during
hospitalization; none had a stroke during follow-up.
Conclusion Patients with an ABCD
2 score ≤ 3 had an equal
chance of requiring IHI as those with a score of 4–7. The
decision to admit TIA patients based on the ABCD
2 score
alone is not supported by our experience and requires
further study.
Keywords Transient ischemic attack.Stroke risk.
Prognosis
Introduction
Because population-based studies have shown that the risk
of stroke after a transient ischemic attack (TIA) is high [1],
immediate evaluation and treatment is warranted. The
ABCD
2 score, which considers age, blood pressure, clinical
features, duration of symptoms, and history of diabetes, has
been shown to predict the short-term stroke risk after TIA
and is being used to triage TIA patients [2]. Based on the
presumed low risk of stroke within the first 2 days after a
TIA, hospital admission may be unnecessary for most
patients with a score ≤ 3 in the absence of atrial fibrillation
(AF). Admission is, however, generally recommended for
patients with a score ≥ 4 to ensure prompt evaluation and
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DOI 10.1007/s12245-010-0176-xintervention to reduce the risk of subsequent early stroke [2,
3]. Recently, the EXPRESS and SOS-TIA studies showed
that urgent evaluation and initiation of preventive treat-
ments, such as antiplatelets, statins, anticoagulation, and
carotid revascularization, greatly reduce the risk of early
stroke after a TIA or minor stroke [4, 5]. Since antiplatelets
and statins can be initiated in the emergency department or
outpatient setting, the added benefit from hospital admis-
sion would be to facilitate timely detection and treatment of
cardioembolic etiology requiring anticoagulation or arterial
stenosis requiring revascularization.
Whether the ABCD
2 score could also predict the need
for urgent in-hospital intervention (IHI), i.e., anticoagula-
tion and revascularization, other than antiplatelets and
statins, is unknown. The score’s ability to predict IHI
would strengthen the rationale for its use as a decision-
making tool to determine which TIA patients should be
admitted. We thus conducted this study to investigate the
relationship between admission ABCD
2 score and IHI
during hospitalization.
Methods
We routinely admit all patients with suspected TIAs
presenting to our emergency department for hospital
observation, regardless of their ABCD
2 score. We prospec-
tively collected the data for consecutive patients admitted
with TIAs to our service from July 2007 to July 2008. TIA
was defined as a sudden onset of focal neurological deficits
or amaurosis fugax, suspected to be of cerebrovascular
origin, lasting less than 24 h and which has resolved prior
to presentation to our emergency department. On admis-
sion, information on the symptoms and duration of TIA
were obtained and the stroke fellows determined the
ABCD
2 score of each patient [2].
For each patient, we recorded the following information:
(1) age and sex; (2) past medical history, especially TIA
and stroke; (3) previously known vascular risk factors (AF,
hypertension, diabetes mellitus, coronary artery disease,
hyperlipidemia, and current smoking); (4) medications taken
at the time of symptom onset (antiplatelets, statins, and
anticoagulants); (5) the results of in-hospital evaluation(s),
including newly diagnosed risk factors for stroke (arterial
stenosis, AF, potential cardioembolic source, diabetes,
hypertension, and hypercholesterolemia); and (6) new
treatments initiated during hospitalization including anti-
platelets, statins, anticoagulation (either parenteral or oral),
and carotid revascularization. Newly diagnosed hyperten-
sion was identified as systolic blood pressure ≥140 mmHg or
diastolic blood pressure ≥90 mmHg on repeated measure-
ments. The threshold for the diagnosis of diabetes was set
as a fasting plasma glucose level >126 mg/dl (7.0 mmol/l)
or a casual plasma glucose >200 mg/dl (11.1 mmol/l).
Hypercholesterolemia was defined as either total cholesterol
>200 mg/dl or low-density lipoprotein cholesterol (LDL-C)
>100 mg/dl, based on the current guidelines for stroke
prevention [6].
The results of evaluations during admission were
collected. As shown in Table 1, they included electrocar-
diogram (ECG), transthoracic echocardiography (TTE),
transesophageal echocardiography (TEE), brain computed
tomography (CT), magnetic resonance (MR) studies in-
cluding diffusion-weighted imaging (DWI), carotid duplex
sonography, MR angiography, or CT angiography, and
electroencephalogram (EEG) when performed to exclude
the possibility of a seizure. Many patients had more than one
imaging modality. We also recorded the presence or absence
of recurrent stroke-like symptoms during hospitalization and
upon follow-up after discharge.
IHI was defined as arterial revascularization or initiation
of anticoagulation during hospital admission due to arterial
Table 1 Clinical characteristics of TIA patients (n=121)
Characteristics Value
Age, years, mean (SD) 65 (15)
Female, n (%) 67 (55)
Past history, n (%)
Hypertension 78 (64)
Diabetes 25 (21)
Coronary artery disease 17 (14)
Hyperlipidemia 59 (49)
Stroke 15 (12)
Smoking 23 (19)
Evaluations during admission, n (%)
CT scan 76 (63)
MRI scan 98 (81)
Echocardiography 102 (84)
TTE 59 (49)
TEE
ECG 121 (100)
Telemetry 121 (100)
CT angiography 42 (35)
MR angiography 112 (93)
Carotid duplex sonography 42 (35)
Treatments during admission, n (%)
Initiate the use of antiplatelets 42 (35)
Change the use of antiplatelets 22 (18)
Initiate the use of statins 39 (32)
Time from first symptom onset to
evaluation, days, mean (SD)
1.5 (3.6)
Time from admission to IHI, days, mean (SD) 1.8 (1.1)
MRI magnetic resonance imaging, TIA transient ischemic attack, SD
standard deviation, IHI in-hospital intervention
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thought to cause the TIA-like neurological symptoms. We
excluded from analysis patients with known or documented
AF upon presentation and those taking warfarin at the time
of symptom onset, since these patients were either
continued or started de novo on warfarin for presumed
cardioembolism regardless of their ABCD
2 scores or results
of in-hospital work-up.
Statistical analysis
We determined the distribution of patients with newly
diagnosed risk factors and IHI by ABCD
2 scores, which
were trichotomized into low- (1–3 points), medium- (4–5
points), and high-risk (6–7 points) groups. We used the
Wilcoxon rank sum test for nonparametric and Fisher’s
exact test for categorical comparisons. Risk associations
were assessed by chi-square (χ
2) for trend. A p<0.05 was
set for statistical significance. Statistical analyses were
performed using SPSS statistical software, version 15
(SPSS Inc., Chicago, IL, USA).
Results
A total of 151 patients with suspected TIAs were admitted to
the hospital during the study period. We excluded 30 patients
with either known AF or those taking warfarin at the time of
symptom onset from our analysis. The clinical characteristics
of the remaining 121 TIA patients are shown in Table 1.T h e
mean age was 65±15 years and 55% were women.
Antiplatelet therapy was either started de novo or changed
from one antiplatelet agent to another in 53% of the patients
during admission. Table 2 shows the distribution of patients
with newly diagnosed risk factors and those requiring IHI by
ABCD
2 scores. Fifty-four patients (45%) had a score ≥ 4.
Fourteen patients (12%) were found to have small infarcts on
DWI, 57% (8/14) of whom had a score ≤ 3. Overall, a higher
percentage (36%) was found to have infarcts among patients
with a score of 6–7, compared to 12% among a score ≤ 3
and 5% among a score of 4–5. However, these differences
were not significant (p for trend=0.29).
The baseline 12-lead ECG was entirely normal in 97 of the
121 patients. Various ECG abnormalities ranging from ST-T
wave changes, conduction defects, and voltage changes
indicative of left ventricular hypertrophy were seen in the
remaining 24 subjects. No patient had AF on telemetry during
hospitalization.Apotentialcardioembolicsourcewasrevealed
in four (3%) patients (three with right-to-left shunt and one
with intracardiac thrombus) by echocardiography. Other risk
factors newly recognized during admission included hyper-
lipidemia (7%, n=9), hypertension (0.8%, n=1), diabetes
(0.8%, n=1), carotid stenosis ≥ 50% (13%, n=16), and other
arterial occlusive lesions (6%, n=7). The percentages of
patients with newly recognized risk factors increased with
higher ABCD
2 scores (24% with ≤ 3, 37% with 4–5, and
55% with 6–7 points; p for trend=0.02).
Ten percent of patients (12/121) required IHI. Seven
percent (n=9) had ≥ 50% ipsilateral carotid stenosis
requiring urgent revascularization, and no patient received
Table 2 Results of in-hospital evaluation of TIA patients, per ABCD
2 score category
Overall (n=121) ABCD
2 score p value
0–3( n=67) 4–5( n=43) 6–7( n=11)
Small infarcts on DWI, n (%) 14 (12) 8 (12) 2 (5) 4 (36) 0.285
New risk factor recognized during admission, n (%) 38 (31) 16 (24) 16 (37) 6 (55) 0.024*
Carotid stenosis >50% 16 (13) 5 (7) 8 (19) 3 (27) 0.028*
Other arterial occlusive lesions 7 (6) 4 (6) 3 (7) 0 (0) 0.653
Hypercholesterolemia 9 (7) 3 (4) 3 (7) 3 (27) 0.028*
Hypertension 1 (0.8) 1 (1) 0 (0) 0 (0) 0.413
Diabetes 1 (0.8) 1 (1) 0 (0) 0 (0) 0.413
Cardioembolic source 4 (3) 2 (3) 2 (5) 0 (0) 0.909
In-hospital intervention (IHI), n (%) 12 (10) 7 (10) 4 (9) 1 (9) 0.837
Revascularization due to ipsilateral carotid stenosis >50% 9 (7) 4 (6) 4 (9) 1 (9) 0.540
Anticoagulation due to other arterial occlusive lesions 2 (2) 2 (3) 0 (0) 0 (0) 0.245
Anticoagulation due to cardioembolic source 1 (0.8) 1 (1) 0 (0) 0 (0) 0.413
Length of hospitalization, days, mean (SD) 2.1 (2.1) 1.7 (1.3) 2.3 (2.9) 3.5 (2.3) 0.024*
TIA transient ischemic attack, DWI diffusion-weighted imaging, SD standard deviation
*A p<0.05 was set for statistical significance
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istics of patients requiring revascularization were not
significantly different from other patients. The attending
clinicians decided to urgently anticoagulate two patients
with other arterial occlusive lesions (one with carotid
dissection and one with high-grade stenosis of the vertebral
artery) and one with a thrombus on the mitral valve. IHI was
equally distributed across all ABCD
2 scores (10% in ≤ 3,
9% in 4–5, and 9% in 6–7; p for trend=0.80). Table 3
shows the characteristics of patients with IHI vs those
without IHI. There were no differences in individual
components of the ABCD
2 score between patients with
and without IHI. A history of coronary artery disease
(CAD) was more prevalent among IHI patients. The vast
majority of patients with IHI were men. More patients with
IHI were found to have small infarcts on DWI, compared
with those without IHI (33 vs 9%; p=0.03).
The mean length of hospitalization was 2.1±2.1 days
(range: 1–18), and increased with higher ABCD
2 scores
(p=0.02). One patient (0.8%) worsened due to a new
ischemic stroke during hospitalization; none had a stroke
during an average of 48±43 days follow-up period.
Discussion
In this cohort of TIA patients, we found no association
between the ABCD
2 score and the need for IHI. Patients
with a score ≤ 3 had an equal chance of requiring IHI as
those with higher scores.
Rapid evaluation and early intervention reduce the risk
of stroke after a TIA [4, 5]. Treatments such as antiplatelet
agents, statins, anticoagulation for patients with AF, and
endarterectomy or stenting for patients with symptomatic
carotid stenosis effectively prevent stroke after TIA [4, 5,
7–12]. Antiplatelets and statins can be easily and safely
initiated in the emergency department or by the primary
care physician as soon as a patient with TIA seeks medical
attention, while adequate anticoagulation and timely endar-
terectomy or stenting often require hospitalization. Al-
though the necessity of expedited evaluation and treatment
of TIA patients is undisputed, routine hospital admission
for all TIA patients may be unnecessary and cost
ineffective. Therefore, a risk stratification score to deter-
mine which TIA patients should be admitted to the hospital
should ideally be able to identify those patients who may
require anticoagulation or carotid revascularization. In
recent years, the ABCD
2 score which was originally
developed to predict the short-term risk of stroke after a
TIA has become increasingly used to triage patients [2, 3].
However, the ability of the ABCD
2 score to predict the
need for IHI has not previously been studied.
We admit all patients with suspected TIAs at our
institution for in-hospital observations and perform urgent
diagnostic testing to determine the underlying cause for the
TIA. This afforded us the opportunity to conduct the
Patients with
IHI (n=12)
Patients without
IHI (n=109)
p value
Total ABCD
2 score, mean (SD) 3.5 (1.4) 3.3 (1.5) 0.707
Age ≥ 60 years old, n (%) 8 (67) 70 (64) 0.867
SBP >140 or DBP ≥ 90 mmHg, n (%) 7 (58) 68 (62) 0.785
Unilateral weakness, n (%) 4 (33) 29 (27) 0.734
Speech disturbance without weakness, n (%) 3 (25) 33 (30) 1.000
Duration ≥ 60 min, n (%) 5 (42) 37 (34) 0.750
10–59 min, n (%) 5 (42) 34 (31) 0.521
Diabetes, n (%) 1 (8) 25 (23) 0.244
Infarcts on DWI, n (%) 4 (33) 10 (9) 0.033*
Demographic characteristics
Age, years, mean (SD) 67 (13) 65 (15) 0.563
Female sex, n (%) 3 (25) 64 (59) 0.033*
Medical history, n (%)
Diabetes 1 (8) 24 (22) 0.456
Hypertension 9 (75) 69 (63) 0.535
Coronary artery disease 5 (42) 12 (11) 0.013*
Hypercholesterolemia 9 (75) 50 (46) 0.071
Prior stroke 3 (25) 12 (11) 0.170
Smoking 3 (25) 20 (18) 0.697
Table 3 Characteristics of
patients with and without IHI
IHI in-hospital intervention, SD
standard deviation, SBP systolic
blood pressure, DBP diastolic
blood pressure, DWI diffusion-
weighted imaging
*A p<0.05 was set for statistical
significance
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ABCD
2 score and IHI. Our finding of an equal distribution
of IHI among patients with low, medium, and high ABCD
2
scores suggests that the decision to admit patients with
suspected TIAs for hospital observation based on the
ABCD
2 score alone is not justified. We also found that
more than half of the patients with transient symptoms who
had small infarcts on diffusion MRI had a low score of ≤ 3,
indicating that the association between the ABCD
2 score
and DWI-positive TIA is poor. This is consistent with
earlier reports indicating that patients with an ABCD score
<4 still have a substantial probability of having radiograph-
ic evidence of acute infarction [13].
Only one patient (0.8%) experienced neurological
worsening due to a new stroke during hospitalization in
our study, and none was noted to have AF on telemetry. We
perform urgent diagnostic testing to determine the TIA
cause in our institution. Patients with relevant ipsilateral
carotid stenosis > 50% generally undergo revascularization
and patients with a cardioembolic source are started on
anticoagulants during hospitalization. Antiplatelets and
statins are either started or modified, as appropriate, in the
emergency department for most patients. This aggressive
approach is likely to account for our low stroke rate, which
is similar to other studies in which TIA patients underwent
urgent evaluation [4, 5] but much lower than other previous
studies in which patients were less rapidly evaluated [14].
Our findings argue that hospital admission of TIA patients
for the sole purposes of observation may be unnecessary; that
telemetry, in patients with no clinical suspicion for a
cardioembolic source and a normal sinus rhythm on 12-lead
ECG without conduction orST-Twavechanges,isunlikelyto
yield significant abnormalities; and that the need for IHI is a
more appropriate determinant for hospital admission rather
than the individual patient’s short-term risk of subsequent
stroke as assessed by the ABCD
2 score. The most frequent
findings leading to IHI among our patients was an ipsilateral
carotid stenosis >50%, and only one patient had a
cardioembolic source revealed by echocardiography which
required anticoagulation during hospitalization. This sug-
gests that imaging TIA patients for carotid occlusive disease
should be urgently done in the emergency department. The
importance of vascular imaging to identify high-risk TIA
patients is highlighted by Hill et al. [14] and Lovett et al.
[15] who showed that recurrent stroke risk varies between
different etiologic subtypes of ischemic stroke and is highest
in patients with large-artery atherosclerosis. The addition of
results from an urgent diagnostic work-up, such as CT scan
and MRI, improves the predictive ability of the ABCD
2
score and suggests that a combined clinical and imaging
assessment of brain and vessels has the potential to increase
the efficient use of resources and rapidly evaluate the
underlying etiology of the TIA patients [16, 17].
We found that patients with IHI had a higher rate of
CAD, indicating that special attention should be paid to
TIA patients with CAD. Carotid stenosis is common in
CAD patients [18, 19]. We also found that IHI was less
frequent among women than men. Women are more likely
to be admitted to the hospital than men [20]. It is uncertain
if the gender-based difference in IHI reflects the higher
prevalence of arterial atherosclerosis in men or the
admission of relatively more women with transient neuro-
logical symptoms that are not TIA.
The strength of our study lies in its prospective nature.
However, our study also has limitations. The small number
of patients, particularly those with a score of 4–7 and those
requiring IHI, reduces the strength of our results. Although
most of our patients were seen within the first 24 h of the
onset of TIA symptoms, they were not all studied in a
uniform manner or at a uniform time in their disease course.
This variability in the time from symptom onset to
evaluation and diagnostic methods may have influenced
the testing results. Furthermore, our study is limited to
patients seen at a single institution, which may limit its
generalizability to other patient populations. Larger-scale
studies are needed to validate our findings and to fully
evaluate the predictive factors of IHI in TIA patients.
In conclusion, we found a poor association between
admission ABCD
2 score and the need for IHI in patients
with TIA. The decision to admit or not admit patients with
suspected TIAs for in-hospital observation based on the
ABCD
2 score alone is not supported by our experience and
requires further study before it can be recommended as a
tool to triage TIA patients. Our study highlights the fact that
much depends on the capability to perform extensive
evaluation in the emergency department using modern
brain, vascular, and cardiac technologies to rapidly eluci-
date the pathophysiology of the TIA in individual patients.
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